Intervention

HLX01

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown1

Clinical trials

2 shown

Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid ArthritisNCT03522415 · 2018-05-28

A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDsNCT03355872 · 2016-02-01

Common conditions

Moderately to Severely Active Rheumatoid Arthritis1 Rheumatoid Arthritis1

Leading sponsors

Shanghai Henlius Biotech2

Trial status mix

COMPLETED2

Phase mix

PHASE11

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.